Disclosure Index: B
	
						
	
	
	
		
Disclosure Index: B
	
		
			
				Shire: 
Consulting fees
, 
involved in clinical trials
 and 
Speakers' bureau
Lilly: Consulting fees and Speakers' bureau
Medice: Consulting fees and Speakers' bureau
Hexal: Consulting fees
Actelion: Consulting fees
Otsuka: Consulting fees
Viforpharma: clinical trial and Consulting fees
Hogrefe, Kohlhammer, CIP Medien, Oxford University Press: Receipt of royalties
PCM scientific: Consulting fees
Lilly: Consulting fees and Speakers' bureau
Medice: Consulting fees and Speakers' bureau
Hexal: Consulting fees
Actelion: Consulting fees
Otsuka: Consulting fees
Viforpharma: clinical trial and Consulting fees
Hogrefe, Kohlhammer, CIP Medien, Oxford University Press: Receipt of royalties
PCM scientific: Consulting fees
		
			
				Janssen Reseach & Development, LLC: 
Employment (full or part-time)
			
		
	
		
			
				MCHAT, LLC: 
Ownership or partnership
 and 
Receipt of royalties
			
		
	
		
			
				Novartis: 
Meetings' registration fee payments
			
		
	
		
			
				Roche Pharmaceuticals: 
Research grants
			
		
	
		
			
				BioMarin: 
Consulting fees
Audentes: Consulting fees
Audentes: Consulting fees
		
			
				ASDDR, LLC: 
Ownership or partnership
			
		
	
		
			
				F. Hoffmann-La Roche: 
Employment (full or part-time)
			
		
	
		
			
				Experiad Solutions: 
Employment (full or part-time)
 and 
Ownership or partnership
			
		
	
		
			
				Janssen Reseach & Development, LLC: 
Employment (full or part-time)
			
		
	
		
			
				F. Hoffmann-La Roche Ltd: 
Employment (full or part-time)
			
		
	
		
			
				Curemark LLC: 
Research grants
 and 
Travel Reimbursement
			
		
	
		
			
				University of Nice Sophia Antipolis: 
Employment (full or part-time)
			
		
	
		
			
				Cognoa: 
Research grants
			
		
	
		
			
				Center for Environmental Health: 
Consulting fees
 and 
Development of environmental health educational curricula for child care programs
Organic Center: Non-remunerative and Volunteer board member
Organic Center: Non-remunerative and Volunteer board member
		
			
				Daniel Brandeis: 
D. Brandeis reports no biomedical financial interests or potential conflicts of interest. He serves as an unpaid scientific advisor for an EU-funded Neurofeedback trial.
			
		
	
		
			
				Metabolon, Inc.: 
Employment (full or part-time)
			
		
	
		
			
				Janssen Cilag: 
Consulting fees
 and 
Speakers' bureau
Lilly: Consulting fees and Speakers' bureau
Medice: Speakers' bureau
Vifar: Research grants
Lundbeck: Consulting fees
Roche: collaboration with IMI grant EU-AIMS
Janssen Cilag: Consulting fees
Lilly: Consulting fees
Shire: Speakers' bureau
Roche: Consulting fees
Lilly: Consulting fees and Speakers' bureau
Medice: Speakers' bureau
Vifar: Research grants
Lundbeck: Consulting fees
Roche: collaboration with IMI grant EU-AIMS
Janssen Cilag: Consulting fees
Lilly: Consulting fees
Shire: Speakers' bureau
Roche: Consulting fees
		
			
				GlaxoSmithKline: 
Employment (full or part-time)
 and 
Stock
Glaxo Smith Kline: Employment (full or part-time) and Stock
Glaxo Smith Kline: Employment (full or part-time) and Stock
		
			
				Stemina Biomarker Discovery: 
Employment (full or part-time)
			
		
	
		
			
				Novartis: 
Research grants
			
		
	
		
			
				Center for Student Research: 
Scholarship 
CSUEB College Link Program: Employment (full or part-time)
CSUEB College Link Program: Employment (full or part-time)
